Psoriatic spondyloarthropathy with secondary amyloidosis

Journal of Rheumatology

Volumn 23, Issue 6, 1996, Pages 1107-1110

  Ahmed, Qasim ^a,c   Chung Park, Moonja ^a   Mustafa, Khader ^a   Khan, Muhammad A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Department of Medicine ^*

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

AMYLOIDOSIS; CARDIAC AMYLOIDOSIS; PSORIASIS; PSORIATIC ARTHRITIS; SPONDYLOARTHROPATHY

Indexed keywords

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; HEART AMYLOIDOSIS; HEART FAILURE; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; KIDNEY FAILURE; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SPONDYLOARTHROPATHY;

ADULT; AMYLOIDOSIS; ARTHRITIS, PSORIATIC; ATRIOVENTRICULAR NODE; AUTOPSY; FEMALE; HLA-B27 ANTIGEN; HUMANS; KIDNEY; MALE; MIDDLE AGED; SPONDYLITIS;

EID: 0030006568     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lavie G, Zucker-Franklin D, Franklin EC: Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med 1978;148:1020-31.
2. Maury CPJ, Teppo AM: Mechanism of reduced amyloid A degrading activity in serum of patients with secondary amyloidosis. Lancet 1982;2:234-6.
3. Kisilevsky R: Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition. J Intern Med 1992;232:515-6.
4. Brownstein MH, Helwig EB: Systemic amyloidosis complicating dermatoses. Arch Dermatol 1970;102:1-7.
5. Gertz MA, Kyle RA: Secondary systemic amyloidosis: Response and survival in 64 patients. Medicine 1991;70:246-56.
6. Johnson RA, Palacios I. Nondilated cardiomyopathies. Adv Intern Med 1984;30:243-74.
7. Clinicopathologic Conference: Intractable heart failure. N Y State J Med 1975;75:1235-46.
8. Bergfeldt L: HLA B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakers. Am J Med 1985;75:210-5.
9. Sun JP, Khan MA, Farhat AZ, Bahler RC: Alteration in cardiac diastolic function in patients with ankylosing spondylitis. Int J Cardiol 1992;37:65-72.
10. Matson MA, Cohen E: Acquired cystic kidney disease: occurrence, prevalence, and renal cancer. Medicine 1990;69:217-26.
11. Ferguson A, Downie WW: Gastrointestinal amyloidosis in psoriatic arthritis. Ann Rheum Dis 1968;27:245-8.
12. Berger PA: Amyloidosis - a complication of pustular psoriasis. BMJ 1969;2:351-3.
13. Qureshi MSA, Sandle GI, Kelly JK, Fox H: Amyloidosis complicating psoriatic arthritis. BMJ 1977;2:302.
14. Friedman R, Agus B, Ames E: Amyloid arthropathy in a patient with psoriasis and amyloidosis. Arthritis Rheum 1981;24:1320-3.
15. Taylor R, Morgan JM, Davie RM: Renal amyloidosis secondary to psoriatic arthropathy. Br J Clin Pract 1981;35:410-1, 414.
16. Willoughby CP, Banerji A, Bennett MK, Jewell DP: Gastrointestinal amyloidosis complicating psoriatic arthropathy. Postgrad Med J 1981;57:663-7.
17. David M, Abraham D, Weinberger A, Feuerman EJ: Generalized pustular psoriasis, psoriatic arthritis and nephrotic syndrome associated with systemic amyloidosis. Dermatologica 1982;165:168-71.
18. Sharma SC, Mortimer G, Kennedy S, Thomson J: Secondary amyloidosis affecting the skin in arthropathic psoriasis. Br J Dermatol 1983;108:205-10.
19. Ekenstam E, Michaelsson G, Hallgren R: Response of secondary amyloidosis in psoriasis to treatment with etretinate and ultraviolet light. BMJ 1986;293:733-4.
20. Fak AS, Ozener C, Akoglu E: Colchicine and secondary amyloidosis. Ann Intern Med 1992;117:795-6.
21. Delgado WA, Mosquedo A: A highly sensitive method for diagnosis of secondary amyloidosis by labial salivary gland biopsy. J Oral Pathol Med 1989;18:310-4.
22. Khan MA, Kellner H: Immunogenetics of spondyloarthropathies. Rheum Dis Clin North Am 1992;18:837-64.
23. Gladman DD: Toward unraveling the mystery of psoriatic arthritis. Arthritis Rheum 1993;36:881-4.
24. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993;101:701-5.
25. Jiang SL, Lozanski G, Samols D, Kushner I: Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1beta involves both transcriptional and post-transcriptional mechanisms. J Immunol 1995;154:825-31.
26. Gertz MA: Secondary amyloidosis. J Intern Med 1992;232:517-8.
27. David J, Vonyioka O, Ansell BM, Hall A, Woo P: Amyloidosis in juvenile chronic arthritis: A morbidity and mortality study. Clin Exp Rheumatol 1993;11:85-90.
28. Livneh A, Zemer D, Langevitz P, Shemer J, Sonar E, Prs M: Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rheum 1993;23:206-14.